Purple Book reference family · 351(a) biologic
Hematopoietic Progenitor Cells, Cord (HPC-C) (Hemacord)
Hematopoietic Progenitor Cells, Cord (HPC-C) is an FDA-licensed reference biologic from New York Blood Center, Inc..
351(a) biologicBLA 125397 New York Blood Center, Inc.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2011
Reference product
Originator biologic
351(a)BLA 125397
Hemacord Hematopoietic Progenitor Cells, Cord (HPC-C)
New York Blood Center, Inc.
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference Hematopoietic Progenitor Cells, Cord (HPC-C) product.
14 yr 11 mo ago
Hematopoietic Progenitor Cells, Cord (HPC-C): frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Hematopoietic Progenitor Cells, Cord (HPC-C).
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
